The management of wounds in patients on anticoagulant therapy who require oral surgical procedures is problematic and often results in a non-satisfactory healing process.
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COMPOSITE ALGINATE-HYALURONAN SPONGES FOR THE DELIVERY OF TRANEXAMIC ACID IN POST-EXTRACTIVE ALVEOLAR WOUNDS
Ovidio
Introduction
Tooth extractions, even if considered as minor oral surgery, are one of the most routinely performed treatments among dental surgical techniques, and like all surgical procedures often cause large socket wounds, particularly after large tooth extraction.
Under normal conditions the management of oral surgical wounds is simple, but for some category of patients, such as those on anticoagulant therapy, it is problematic and still controversial. Generally, when tooth extraction is required in such patients, the pharmacological therapy is reduced or stopped for several days before the surgery, increasing the risks of uncontrolled bleeding and, most of all, thromboembolism, which is considered a major complication [1] [2] [3] . However, a different approach based on the use of local hemostatic agents would make it possible to operate without any interruption or diminution of the anticoagulant treatment, avoiding risks caused by clogged blood flow due to suspending drug regimen [4] [5] [6] .
The term "socket healing" generally refers to a series of local alterations that arise in both hard and soft tissues in order to close the socket wound after tooth extraction and to restore tissue homeostasis 7 . The most common complication following tooth extractions is the alveolar osteitis (dry socket) which may develop when an inflammation of the alveolar bone occurs, resulting in intense pain and delayed wound healing 8, 9 . Dry socket is often a consequence of the removal or dissolution of the blood clot at the site of the tooth extraction before the wound has healed 10 . During tooth extraction, the formation of a blood clot is essential because it serves as a protective layer over the underlying bone and nerve endings in the empty tooth socket. The clot also provides the foundation for the growth of new bone and for the development of soft tissue.
For this purpose, an advanced wound dressing able to control wound bleeding and enhance clot formation could be very useful for the prevention of alveolar osteitis and pain following tooth extraction. The wound dressing can act both as socket plug limiting the bleeding, but also as a local release platform for different drugs, including antifibrinolytics.
In particular, the association of tranexamic acid (TA) with postoperative compression showed good results in preventing postoperative bleeding 6, 11 . TA was already widely used as mouthwash 12 or as socket irrigation immediately after extraction 13 to prevent post extraction bleeding in patients on warfarin. However, this approach exhibits several limitations such as poor handiness and control over the delivered dose, as well as poor efficiency due to bleeding, which tends to quickly wash out the drug away from the administration site.
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Macroporous alginate (ALG) sponges are considered a very interesting platform system for local drug release, and for this purpose, they have been extensively developed for a wide range of applications, such as bone tissue engineering, wound dressing and drug delivery [14] [15] [16] . Through the years ALG has gained a leading role among the wound dressing materials due to peculiar characteristics including the high absorbency and the promotion of healing and epidermal regeneration 15 . Its natural origin and simple extraction process from marine brown algae biomass, associated with their characteristics in term of biocompatibility and biodegradability under physiological conditions, make this polysaccharide ideal for use as socket-dressing materials 17 . Furthermore, it has been demonstrated that calcium alginate materials activate platelet and blood coagulation and for this reason, they have also been used as hemostatic dressings 18 . recently proposed by our group as a versatile and straightforward strategy to obtain homogenous cross-linked composite ALG hydrogels 22, 23 . In addition, we found that the integration of hyaluronan (HA), an extracellular glycosoaminoglycan extensively involved in all phases of wound healing 24 and, in these ionically cross-linked ALG matrix has proved to be a versatile strategy to promote the wound healing process. Beside its function as the main component of extracellular matrix and cartilage, HA is also an important component of both soft periodontal tissues such as gingiva and periodontal ligament and of the hard tissue, such as alveolar bone and cementum. For these reasons, as recently reported by
Casale et al.
25
, the topical application of HA could have a positive action on the healing of mineralized and non-mineralized tissues of the periodontium. Moreover, a recent pilot study in dogs demonstrated how HA may enhance bone formation and accelerate wound healing in infected sockets 26 .
In this work, we present an alginate/hyaluronan (ALG/HA) based composite sponge dressing loaded with TA useful for reducing bleeding after tooth extraction and, at the same time, reducing the risk of alveolar osteitis. Moldable, biocompatible, and bioresorbable dressing were prepared by internal gelation followed by a freeze-drying to obtain solid macroporous sponges loaded with TA. The gradual release of calcium ions directly from the inside of an ALG solution results in a homogeneous crosslink, with M A N U S C R I P T
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consequent improved mechanical properties, and allow an easy integration and a uniform distribution of drugs that are soluble in hydrogels or aqueous solutions. We examined in depth the behaviour of the sponges when they came in contact with simulated biological fluids, evaluating the swelling rates, the degradation behaviour and the drug release in relation to the composition and to the microstructure of the sponges. The mechanical properties and the adhesion profile on a simulated wound surface were also evaluated.
Finally, the in vitro toxicity of the platform was tested in normal adult human primary epidermal keratinocyte cell lines and hemostatic efficacy evaluated through an in vitro dynamic whole blood clotting test. 10 and ALG/HA 20 , respectively) was prepared and gelled with a freshly prepared GDL solution as previously described 27, 28 . , and gelled on a horizontal surface at room temperature for 24 h.
After gelation, the ALG disks were washed with deionized water, frozen overnight at −20°C, and then lyophilized at 0.01 atm and -60°C i n a Modulyo apparatus (Edwards, UK).
The freeze dried sponges were stored at room temperature under vacuum.
Physical characterization of sponge
The bulk morphology of the ALG/HA sponge was analyzed through scanning electron microscopy (SEM). Samples were mounted on a metal stub by means of carbon adhesive tape and coated with a 20 nm thick gold/palladium layer with a modular high-vacuum coating system Emitech K575X. Images at different magnification were acquired using ). An average value of five replicates for each sample was taken.
The density (ρ) of the sponge was calculated according to the equation 2:
The pore mean diameters were calculated from the SEM images using the public domain Image J software (NIH, Bethesda, MD, USA).
To measure the water retention rate, sponge samples (n = 3) were soaked in water for 30 min then carefully removed and placed in a centrifuge tube. The sponge was centrifuged at 3500 rpm for 3 min to eliminate the excess water, and the wet weight was recorded. Water retention rate (WR) was calculated according the equation 3 below:
Where M h (g) is the weight of the sponge after centrifugation, and M d (g) is the initial dry weight. An average value of five replicates for each sample was taken.
Thermogravimetric analysis (TGA) was performed to estimate the amount of residual moisture in the lyophilized sponges. Samples (n = 4) weighing between 3 and 6 mg were placed in a previously weighted 70 µL aluminum crucible and a dynamic phase of heating at a rate of 10°C/min from ambient temperature to 2 00°C was applied under a constant stream of dry nitrogen using a Thermal Advantage 2950 TGA system (TA Instruments, M A N U S C R I P T
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Crawley UK). The percentage residual moisture was estimated from the weight loss using a TA Universal Analysis 2000 software.
Mechanical properties and degradation behavior
To investigate the resistance to deformation of the freeze-dried sponges a Texture Analyser (Stable Microsystems Ltd., Surrey, UK) equipped with 5 kg load cell and Texture Exponent-32 ® software program was employed. A 6-mm cylindrical stainless steel probe (P6 probe, Stable Microsystems Ltd., Surrey, UK) was used in compression mode. The resistance to deformation ('hardness') was investigated by compressing five ALG or ALG/HA sponges at three different locations to a depth of 2 mm at a speed of 1 mm/s using a trigger force of 0.001 N to determine the effects of HA on the force-time profiles during deformation by compression.
The in vitro mucoadhesive properties of sponges were performed using the same apparatus but in tension mode. A 6.67% w/v gelatin solution was allowed to set as solid gel in a Petri dish (diameter 88 mm) and used to simulate a gingiva surface. The samples (n = 5) were attached to a 75 mm diameter probe using double-sided adhesive tape. 0.5 mL of phosphate buffer saline (PBS, NaCl 120 mM, KCl 2.7 mM, Na 2 HPO 4 10 mM) at pH . The stickiness to the wound surface was calculated from the maximum force required to detach the sponge from the model surface and it is known as peak adhesive force (PAF). The total work of adhesion (TWA) was represented by the area under the force versus distance curve, whereas cohesiveness was defined as the distance traveled by sponge till detached and calculated using the Texture Exponent-32 ® software.
Water uptake
Water uptake was determined by placing the ALG/HA sponges in water. Three circular samples of 15 mm diameter were obtained from a 24-well culture plate. The initial weight of each sample was accurately recorded using an analytical balance, and then they were placed in 5 mL of water in a thermostatic bath at 37° C. Samples were taken out, excess water was carefully removed using tissue paper, and after being weighed were re- Where W is the mass of the swollen sample and W 0 is the mass of the initial dry sample. The equilibrium water content (EWC) percent was calculated by equation 5:
Where W e is the mass of the swollen sample at equilibrium and W d is the mass of the dry sample at equilibrium.
In vitro drug release
The in vitro release profile of TA from ALG and ALG/HA sponge matrix was evaluated in PBS at pH 7.4. TA loaded sponges were incubated in 10 mL of PBS and placed in a thermostatic bath at 37° C. At schedule d time intervals, the release medium was withdrawn and replaced with the same volume of fresh medium. The supernatant was analyzed for TA content by an indirect method using a UV-vis spectrophotometer after derivatization with fluorescamine according the method described by El-Aroud et al.
29
.
Briefly, TA samples were diluted 1:2 by volume in a fluorescamine solution at 0.5% (w/v) in ethanol and incubated in the dark at room temperature for 1 h before analysis. The absorbance of TA samples was measured at 390 nm using a Shimadzu 1800 spectrophotometer (Shimadzu, Japan) fitted out with a 1 cm quartz cell (Hellma, Germany). The linearity of the response was verified over the concentration range 5-100 µg/mL (r 2 ≥0.999).
Biocompatibility studies
Cell viability studies were performed on normal adult human primary epidermal 
In vitro dynamic whole blood clotting studies
Human blood was collected from healthy volunteers (n = 5) and anti-coagulated with acid citrate dextrose tube (20 mM citric acid, 110 mM sodium citrate, 5 mM D-glucose).
The blood clotting test was performed as described by Ong et al.
31
. Briefly, 300 µL of acid citrate dextrose (ACD)-whole blood was slowly dropped on the surface of a sponge dressing placed into a 50 mL polypropylene tubes. Once the sponges were completely The BCI is correlated to the number of RBCs entrapped into the cloth, so as the BCI index raises, blood clotting decreases.
Statistical analyses
Statistical analyses were undertaken using GraphPad Prism 
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Results and Discussion
Preparation and characterization of ALG and ALG/HA sponges
Freeze-drying, which can prevent the destruction of the porous structure during the removal of water, was adopted in the preparation of crosslinked sponges starting from hydrogels obtained by internal gelation (Fig.1A) . The freezing method is useful to obtain regular pore sizes since the sponge porosity is directly correlated with the size of the ice crystal formed during the freezing stage of the freeze-drying process 21 . . The ALG/HA sponges were imaged by SEM. The surface of ALG sponge exhibited a random highly porous structure with interconnected pores with a size in the range of 300−500 µm. This highly porous structure is of utmost importance to ensure water absorption and mechanical strength, especially if an application as socket dressing is envisaged. However, it is worth to notice that from SEM images the microstructure of the ALG sponge (Fig. 1B) appears slightly different from the one of the ALG/HA sponges ( Fig. 1C-D) . In particular, the micrographs of the sponge of ALG alone showed relatively thinner walls with a visible interconnecting pore networks below the surface, differently than the ALG/HA sponge.
Water absorption (WA) and water retention (WR) are two very important properties for sponge materials, which are highly dependent on their inherent structure and morphology. Values of porosity (P), WA and WR for the various ALG/HA sponges are summarized in Table 1 . . In this case is probably the uniform and solid porous structure of crosslinked sponges that "lock" the water molecules and prevent the easy runoff of water.
Mechanical properties
A post extraction socket dressing should have specific mechanical properties to serve as a therapeutic device and, at the same time, as a mechanical obstruction to bleeding. Periodontal dressing materials should be slow-setting to allow manipulation and to create a smooth surface causing no irritation, should be flexible enough to withstand distortion and displacement, should be adhesive and coherent without being bulky, and must have the dimensional stability to prevent salivary leakage and plaque accumulation 34 .
However, to date, there are no exact and standardized reproducible techniques to evaluate these properties. For this kind of dressing the resistance to deformation (hardness) is a valuable physical property that can affect the material clinical behavior both during the application and during its adaptation to the tissues. Another physical property evaluated in this study was the adhesive properties of the sponge dressings on a simulated wet gingival surface. A dressing with good adhesive properties is especially important not only for an easy placing and retention, but also considering its role in the prevention of microbial penetration. The adhesion profile was evaluated through measurement of the peak adhesive force (PAF), the total work of adhesion (TWA) and the cohesiveness, three parameters directly influenced by the physicochemical properties of the sponges such as the pore size distribution and the consequent hydration capacity 35 . In particular, PAF was used as a measure of the in vitro wound adhesive performance (Fig. 2B ). The ALG sponges had a lower PAF (0.34 ± 0.1 N) compared to the ALG/HA 20 (0.69 ± 0.06 N), with an increasing trend proportional to the presence of HA. The same increasing trend appears in WOA and cohesiveness. In general, adhesion properties depend on the hydration capacity of the porous materials where a more rapid initial hydration and consequent more rapid entanglement between the polysaccharide chains and the wound surface which causes a higher dressing adhesion.
In this case, the differences in all the three parameters considered could be attributed to M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
the hydrophilic nature of HA which promotes the interaction between the sponges and the simulated wound environment probably due to the faster initial hydration.
Water uptake and drug release from ALG/HA sponge
The ability to absorb high amounts of fluids is essential to envisage a use of these systems as hemostatic dressings. Generally, for any advanced dressing an high absorption capacity is considered to be beneficial in all the applications where great amounts of biological fluids were produced 15 . Moreover, a dressing capable of a rapid absorption of plasma may also directly contribute to the hemostasis by trapping the anticoagulant factors, which are normally present into the blood stream. Because the dressings can rapidly absorb plasma, the anticoagulant factors are separated from whole blood, resulting in a quick clotting of blood cells by activating the inherent clotting system 36 .
In case of drug loaded dressings, the drug release process is generally strictly related to the fluid absorption kinetic, which is in turn affected by sponge physical structure. For these reasons, the water absorption kinetics of ALG and ALG/HA sponges were carefully evaluated, and the results are shown in Fig. 3A .
In contrast to EWC, the water absorption kinetics were influenced by the presence of HA in the sponge. The absorption curves of the ALG/HA hydrogels showed a higher rate of water uptake within the first 6 h of immersion (equilibrium swelling) as compared with ALG sponges, while after 24 h all the formulations displayed similar water uptake.
However, a difference in porosity does not seem to be the main determinant to explain water uptake kinetics. Nevertheless, the high hydrophilic and polyanionic character of HA 33 may lead to an increase of the hydrostatic pressure within the sponge and enhance its hydration rate.
The release of hydrophilic molecules from swellable sponges mainly depends on water uptake kinetics, thus pointing to the presence of HA as a key parameter in affecting the release rate. For application in bleeding wounds a fast release of the hemostatic agent from the dressing is an essential property, and for this reason, the impact of matrix composition on drug release from loaded sponges was investigated. TA, a drug with well know hemostatic properties, was loaded into the sponges and its release followed to evaluate the ability of the system to reduce bleeding upon wound application. The ALG sponge showed the slowest release rate, whereas the presence of HA accelerated it (Fig.   3B ). Comparison between the release profiles of TA and water uptake curves highlight that the water uptake reached over 70% of its final value in 3 h while in the same period almost 95% of TA is released. Thus, the swelling process peaks in 6 h, when all TA has been M A N U S C R I P T
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released. The incorporation of HA in the composite sponges significantly affected TA release profile because it causes a faster water absorption with a consequent larger burst effect. The faster water absorption also affects sponges degradation in vitro (supplementary materials S2). The behavior of the sponges when in contact with a simulated biological fluid is correlated with the HA concentrations (Fig. S1 ), whose presence leads to a faster loss of the three-dimensional structure. However, for ALG/HA sponges this loss of structural integrity occurred after 7 days from the contact, giving and appropriate contact time for ensure the drug release and a mechanical contribution to hemostasis. On this basis, ALG/HA 20 providing the fastest TA release was selected for cell studies.
Biocompatibility studies
Cytotoxicity test is a fast method to screening medical devices and provide predictive evidence of material biocompatibility. Biocompatibility of ALG and ALG/HA sponges loaded with TA was evaluated on normal human keratinocytes which play an important role in cell migration during normal wound healing. show that all the formulated sponge could be considerate as biocompatible and generally safe.
Whole blood clotting studies
The pro-coagulant properties of sponges loaded with TA were evaluated on ACDhuman whole blood after 10 min of contact. After this time, the RBCs that were not trapped in the clot on the surface of dressing were hemolyzed and quantified using a spectrophotometer. In this case, higher absorbance values indicate a slower clotting rate.
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As shown in Fig. 5 , even when dispersed in ALG/HA sponges, TA was able to induce blood clotting. When human blood was incubated with TA loaded sponges the BCI was significantly reduced by 40% compared to negative control and by 30% compared to ALG/HA 20 sponges. It has been already reported that HA can interfere with blood coagulation inhibiting platelet adhesion and aggregation and prolonging bleeding when administered systemically 37 or when used as a coating for biomedical devices 38 . However, in TA-loaded sponges, this anticoagulant activity related to HA was not evident. Taken together these data demonstrate how using different concentration of HA, it was possible to modulate the mechanical and release characteristics of this composite sponge dressing preserving their pro-coagulant activity.
Conclusions
The aim of this study was the development of a biocompatible dressing able to fit the tridimensional post extractive alveolar cavity, ensuring a pharmacological and mechanical contribution to the hemostasis. ALG/HA sponges loaded with TA were prepared in a twostep procedure starting from a crosslinked hydrogel with a freeze-drying method. ALG/HA sponges with various HA contents showed a porous morphology with an interconnecting network and a pore size related to the amount of HA in the formulation. Swelling studies and texture analysis also confirmed the effect of HA on porosity and on water uptake that results in an improved adhesive properties and a fast drug release. Once confirmed the biocompatibility, a blood clotting test was successfully performed confirming the capacity of these sponges to have a direct action on blood clotting.
Though further studies are needed to evaluate the in vivo blood clotting action of ALG/HA sponges, we can conclude that these dressings seem to be a very promising system for the management of uncontrolled bleeding in patients on anticoagulant therapy. 
